Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis. - Contacts and Locations

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00033371

Locations


United States, Ohio
	Cleveland Clinic Taussig Cancer Center	Recruiting
	Cleveland, Ohio, United States, 44195
	Contact: Clinical Trials Office - Cleveland Clinic Taussig Cancer Cente 866-223-8100

United States, Texas
	M. D. Anderson Cancer Center at University of Texas	Recruiting
	Houston, Texas, United States, 77030-4009
	Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U 713-792-3245

United Kingdom, England
	St. Mark's Hospital	Recruiting
	Harrow, England, United Kingdom, HA1 3UJ
	Contact: Robin K.S. Phillips, MD 44-20-8235-4251 marie.gun@cancer.org.uk

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Patrick M. Lynch, MD, JD	M.D. Anderson Cancer Center